Back to Agenda
An Industry Collaboration on Pharmacovigilance Analytics
Session Chair(s)
Andres Gomez, PhD, MPH
Vice President, Head of Epidemiology, Safety Science, and Analytics
Bristol-Myers Squibb, United States
This session will discuss an initiative and how it is facilitating biopharmaceutical companies to enable earlier and systematic identification of potential safety issues to help minimize harm to patients, improve quality of analytic methods to improve product development, and deliver accelerated method development through collaboration and piloting. Join the Clinical Safety & Pharmacovigilance Community for a follow up Round Table discussion on Wednesday, June 26, 12:45-1:45PM in the DIA Community Zone 1, Sails Pavilion.
Learning Objective : Discuss methods for collaborating and innovating in analytics to improve patient safety; Identify how to build awareness of opportunities for greater alignment across the industry in signal detection and management; Describe industry best practices of current and future signal detection and management.
Speaker(s)
Panelist
John Van Stekelenborg, PhD, MBA, MSc
Johnson & Johnson, United States
Director, Group Lead, Methods and Analysis
Panelist
Neal Grabowski, MBA, MS
Sanofi, United States
TransCelerate IAO Workstream Lead; Head, Signal Management
Have an account?